Have a personal or library account? Click to login
Pheochromocytoma, Fulminant Heart Failure, and a Phenylephrine Challenge. The Perioperative Management of Adrenalectomy in a Jehovah’s Witness Patient: A Case Report Cover

Pheochromocytoma, Fulminant Heart Failure, and a Phenylephrine Challenge. The Perioperative Management of Adrenalectomy in a Jehovah’s Witness Patient: A Case Report

Open Access
|Nov 2021

Figures & Tables

Fig. 1

Hemodynamic fluctuations during hospitalization. Time markers for initiation of beta blockade and surgery are superimposed.

Perioperative goals for pheochromocytoma, stress cardiomyopathy, and acute decompensated heart failure [19]

PheochromocytomaStress CardiomyopathyADHF
PreoperativeAlpha BlockadeAfterload reductionAfterload reduction
OptimizationAntiarrhythmicAntiarrhythmicAntiarrhythmic/ICD
Volume loadingDiureticsDiuretics
Beta BlockadeBeta blockade/ACEI (chronicBeta blockade/ACEI (chronic
stage/recovery) MCSstage/recovery) MCS

IntraoperativeAfterload reduction Vol-Afterload reductionMaintain cardiac output
Hemodynamic Goalsume resuscitationAvoid volume overloadAvoid volume overload

Expected Recovery10 days - 6 weeks1-4 weeksChronic, progressive
DOI: https://doi.org/10.2478/jccm-2021-0038 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 55 - 60
Submitted on: Apr 6, 2021
|
Accepted on: Oct 10, 2021
|
Published on: Nov 13, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Sarah A. Bachman, Ryan S. Peterson, Peter S. Burrage, Leigh C Hickerson, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.